These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39138896)

  • 1. Pharmaceutical Pollution of the English National Parks.
    Boxall ABA; Collins R; Wilkinson JL; Swan C; Bouzas-Monroy A; Jones J; Winter E; Leach J; Juta U; Deacon A; Townsend I; Kerr P; Paget R; Rogers M; Greaves D; Turner D; Pearson C
    Environ Toxicol Chem; 2024 Nov; 43(11):2422-2435. PubMed ID: 39138896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical pollution of the world's rivers.
    Wilkinson JL; Boxall ABA; Kolpin DW; Leung KMY; Lai RWS; Galbán-Malagón C; Adell AD; Mondon J; Metian M; Marchant RA; Bouzas-Monroy A; Cuni-Sanchez A; Coors A; Carriquiriborde P; Rojo M; Gordon C; Cara M; Moermond M; Luarte T; Petrosyan V; Perikhanyan Y; Mahon CS; McGurk CJ; Hofmann T; Kormoker T; Iniguez V; Guzman-Otazo J; Tavares JL; Gildasio De Figueiredo F; Razzolini MTP; Dougnon V; Gbaguidi G; Traoré O; Blais JM; Kimpe LE; Wong M; Wong D; Ntchantcho R; Pizarro J; Ying GG; Chen CE; Páez M; Martínez-Lara J; Otamonga JP; Poté J; Ifo SA; Wilson P; Echeverría-Sáenz S; Udikovic-Kolic N; Milakovic M; Fatta-Kassinos D; Ioannou-Ttofa L; Belušová V; Vymazal J; Cárdenas-Bustamante M; Kassa BA; Garric J; Chaumot A; Gibba P; Kunchulia I; Seidensticker S; Lyberatos G; Halldórsson HP; Melling M; Shashidhar T; Lamba M; Nastiti A; Supriatin A; Pourang N; Abedini A; Abdullah O; Gharbia SS; Pilla F; Chefetz B; Topaz T; Yao KM; Aubakirova B; Beisenova R; Olaka L; Mulu JK; Chatanga P; Ntuli V; Blama NT; Sherif S; Aris AZ; Looi LJ; Niang M; Traore ST; Oldenkamp R; Ogunbanwo O; Ashfaq M; Iqbal M; Abdeen Z; O'Dea A; Morales-Saldaña JM; Custodio M; de la Cruz H; Navarrete I; Carvalho F; Gogra AB; Koroma BM; Cerkvenik-Flajs V; Gombač M; Thwala M; Choi K; Kang H; Ladu JLC; Rico A; Amerasinghe P; Sobek A; Horlitz G; Zenker AK; King AC; Jiang JJ; Kariuki R; Tumbo M; Tezel U; Onay TT; Lejju JB; Vystavna Y; Vergeles Y; Heinzen H; Pérez-Parada A; Sims DB; Figy M; Good D; Teta C
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecological Risk Assessment of Pharmaceuticals in the Transboundary Vecht River (Germany and The Netherlands).
    Duarte DJ; Niebaum G; Lämmchen V; van Heijnsbergen E; Oldenkamp R; Hernández-Leal L; Schmitt H; Ragas AMJ; Klasmeier J
    Environ Toxicol Chem; 2022 Mar; 41(3):648-662. PubMed ID: 33818825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Potential Ecotoxicological Effects of Pharmaceuticals in the World's Rivers.
    Bouzas-Monroy A; Wilkinson JL; Melling M; Boxall ABA
    Environ Toxicol Chem; 2022 Aug; 41(8):2008-2020. PubMed ID: 35730333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread occurrence and potential for biodegradation of bioactive contaminants in Congaree National Park, USA.
    Bradley PM; Battaglin WA; Clark JM; Henning FP; Hladik ML; Iwanowicz LR; Journey CA; Riley JW; Romanok KM
    Environ Toxicol Chem; 2017 Nov; 36(11):3045-3056. PubMed ID: 28636199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconnaissance Survey of Organic Contaminants of Emerging Concern in the Kabul and Swat Rivers of Pakistan.
    Schilling Costello MC; Asad N; Haris M; Yousefi P; Khan B; Lee LS
    Environ Toxicol Chem; 2023 Dec; 42(12):2599-2613. PubMed ID: 37750569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the extent of pharmaceuticals in surface waters of the United States using a National-scale Rivers and Streams Assessment survey.
    Batt AL; Kincaid TM; Kostich MS; Lazorchak JM; Olsen AR
    Environ Toxicol Chem; 2016 Apr; 35(4):874-81. PubMed ID: 26562077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regional assessment of chemicals of concern in surface waters of four Midwestern United States national parks.
    Elliott SM; VanderMeulen DD
    Sci Total Environ; 2017 Feb; 579():1726-1735. PubMed ID: 27932214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human health risk assessment of pharmaceuticals in the European Vecht River.
    Duarte DJ; Oldenkamp R; Ragas AMJ
    Integr Environ Assess Manag; 2022 Nov; 18(6):1639-1654. PubMed ID: 35112470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals in water, fish and osprey nestlings in Delaware River and Bay.
    Bean TG; Rattner BA; Lazarus RS; Day DD; Burket SR; Brooks BW; Haddad SP; Bowerman WW
    Environ Pollut; 2018 Jan; 232():533-545. PubMed ID: 29032907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Nairobi River catchment impact zone and occurrence of pharmaceuticals: Implications for an impact zone inclusive environmental risk assessment.
    Bagnis S; Boxall A; Gachanja A; Fitzsimons M; Murigi M; Snape J; Tappin A; Wilkinson J; Comber S
    Sci Total Environ; 2020 Feb; 703():134925. PubMed ID: 31726303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive contaminants of emerging concern in National Park waters of the northern Colorado Plateau, USA.
    Weissinger RH; Blackwell BR; Keteles K; Battaglin WA; Bradley PM
    Sci Total Environ; 2018 Sep; 636():910-918. PubMed ID: 29729508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Concentrations of Pharmaceuticals in a Nigerian River Catchment.
    Ogunbanwo OM; Kay P; Boxall AB; Wilkinson J; Sinclair CJ; Shabi RA; Fasasi AE; Lewis GA; Amoda OA; Brown LE
    Environ Toxicol Chem; 2022 Mar; 41(3):551-558. PubMed ID: 32955757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental Risk Assessment of Active Human Pharmaceutical Ingredients in Urban Rivers in Japan.
    Suzuki T; Kosugi Y; Watanabe K; Iida H; Nishimura T
    Chem Pharm Bull (Tokyo); 2021; 69(9):840-853. PubMed ID: 34470948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritizing Pharmaceutical Contaminants in Great Lakes Tributaries Using Risk-Based Screening Techniques.
    Pronschinske MA; Corsi SR; DeCicco LA; Furlong ET; Ankley GT; Blackwell BR; Villeneuve DL; Lenaker PL; Nott MA
    Environ Toxicol Chem; 2022 Sep; 41(9):2221-2239. PubMed ID: 35852176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting monitoring data in environmental exposure modelling and risk assessment of pharmaceuticals.
    Boxall AB; Keller VD; Straub JO; Monteiro SC; Fussell R; Williams RJ
    Environ Int; 2014 Dec; 73():176-85. PubMed ID: 25127044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecological impact of pharmaceutical pollutants and options of river health improvements - A risk analysis-based approach.
    Singh PK; Ranjan N
    Sci Total Environ; 2024 Jun; 928():172358. PubMed ID: 38614331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical, biological, and ecotoxicological assessment of pesticides and persistent organic pollutants in the Bahlui River, Romania.
    Neamtu M; Ciumasu IM; Costica N; Costica M; Bobu M; Nicoara MN; Catrinescu C; van Slooten KB; De Alencastro LF
    Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S76-85. PubMed ID: 19229579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks.
    Tewari S; Jindal R; Kho YL; Eo S; Choi K
    Chemosphere; 2013 Apr; 91(5):697-704. PubMed ID: 23332673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected pharmaceuticals entering an estuary: Concentrations, temporal trends, partitioning, and fluxes.
    Cantwell MG; Katz DR; Sullivan JC; Ho K; Burgess RM; Cashman M
    Environ Toxicol Chem; 2016 Nov; 35(11):2665-2673. PubMed ID: 27062058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.